We’re pleased to announce the recent signing of another commercial stage pharmaceutical company that has selected SimpleCTMS to help them manage the broad number of studies that support their current commercial products and their pipeline of drug candidates in development.
The company, based out of the Research Triangle Park area in North Carolina, designs, optimizes and develops novel small molecule drugs involved in rare diseases. Current activities include several ongoing Phase I and II development programs, as well as recent FDA approval of their commercial product for the treatment of influenza.
“This client came to us with a shot-term need to efficiently manage study activities for their US and European efforts, said Nancy Cecchettini, co-founder and Chief Product Officer. We were able to quickly progress through the adoption period, develop custom electronic visit reports and assist with the functional training for field CRAs in advance of their fast-approaching first patient enrolled milestone. This particular client experienced firsthand how the addition of an easy-to-adopt and easy-to-use workflow solution such as SimpleCTMS can be seamlessly introduced to make study management tasks more efficient.”
To find out more how SimpleCTMS can help you optimize your ciinical study management, check out an upcoming webinar and demo of SimpleCTMS! There's no cost but signing up in advance is required.